AUDITED RESULTS for the year ended 30 June 2022 -- 1 of 66 -- 2 +5% new business API, including DH take- on of new closed schemes and gross revenue for Vitality Group Core new business +6% to R21 710m Normalised operating profit +45% to R9 384m Normalised headline earnings +71% to R5 816m Headline earnings +74% to R5 204m GLOBAL -- 2 of 66 -- 3 30 years of organic growth - 1 000 2 000 3 000 4 000 5 000 6 000 7 000 8 000 9 000 10 000 Operating profit (Rm) R9 384m Operating profit “Make people healthier and enhance and protect their lives” -- 3 of 66 -- 4 Navigating COVID-19 Inflation, recession, market volatility Russia-Ukraine war and geo- political tensions Period saw increased macro environment uncertainty High inflation CPI inflation rates -2% 0% 2% 4% 6% 8% 10% Jul-20 Oct-20 Jan-21 Apr-21 Jul-21 Oct-21 Jan-22 Apr-22 SA US UK China FY 2022 FY 2021 Indices rebased to July 2020 80 90 100 110 120 130 140 150 160 Jul-20 Oct-20 Jan-21 Apr-21 Jul-21 Oct-21 Jan-22 Apr-22 SWIX (SA) S&P 500 (US) SSE (China) FTSE 100 (UK) FY 2022 FY 2021 Market volatility Rising interest rates 0.0% 0.5% 1.0% 1.5% 2.0% 2.5% 0% 2% 4% 6% 8% 10% 12% 14% Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 SA single nominal rate UK 25 yr SONIA Swap SA and UK FY22 FY21 FY20 COVID-19 deaths 0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 16,000 18,000 Jun-20 Oct-20 Feb-21 Jun-21 Oct-21 Feb-22 Jun-22 SA excess deaths FY 2022 FY 2021 -- 4 of 66 -- 5 Positioned for growth off a strong foundation 1 2 3 4 Robust growth, navigating COVID-19 and macroeconomic volatility Pivoting off the Shared-value model to manage the complexities of the period under review Scaling and streamlining the New initiatives Ensuring capital strength and liquidity R77bn Gross income 470m Healthy activities R9.4bn Profit R21.7bn New business 39 Markets >30m Customers 1 business model 13 552 People The leading new generation financial services organisation which through its Vitality Shared-value model makes customers healthier, provides better and more sustainable products, achieves superior growth and returns for its shareholders and is a force for good in the communities in which it operates -- 5 of 66 -- 6 Strong operating profit growth despite COVID-19 and organically building New initiatives Operating profit Rm - 2,000 4,000 6,000 8,000 10,000 12,000 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 +45% Investment in New Pandemic Macro - 2,000 4,000 6,000 8,000 10,000 12,000 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 SA COVID-19 provision impact Investment New -- 6 of 66 -- 7 Health 3 600 +5% 7 292 +20% Life 4 028 +200% 2 543 +12% Invest 1 204 +11% 2 920 +7% Insure (162) -165% 1 246 -3% Core SA 8 670 +42% 14 001 +13% Vitality Health 1 328 +39% 1 738 +27% Vitality Life 671 +4% 1 256 +10% Core UK 1 999 +25% 2 994 +19% Vitality Group 473 +13% 1 398 +10% Ping An Health 338 -18% 2 883 -15% Core VG 811 -2% 4 281 -8% Bank (990) -10% Other New (1 115) +14% 1 576 -25% +6% Core new business API* R21.7bn +45% Operating profit R9.4bn Strong growth ZARm Insurance entities only *Core new business API excludes DH take-on of new closed schemes and gross revenue for Vitality Group Robust profit growth and excellent new business growth. DHMS’ pricing strategy continues to balance short-term affordability with long-term sustainability Resilient performance driven by positive overall experience and COVID-19 experience consistent with provision modelling Robust performance despite lower market levels over second half of period. Launched Cogence, SA’s first Shared-value DFM with BlackRock (Aladdin WealthTM Technology) Difficult period, R369m claims overrun, mainly due to adverse weather events, notably KZN floods, combined with motor parts inflation dramatically exceeding CPI Excellent operating performance driven by sustained membership growth, rigorous expense controls and excellent care management Robust performance as a result of management actions taken over previous reporting periods. Concluded the long-term deferral of the Part VII transfer of VL Strong growth from existing operations and operating model efficiencies unlocked by formation of Vitality Network and Vitality Health International PAH generated R1.3bn lower investment income than prior period however business fundamentals remain strong. New business on PAH insurance licence increased; total new business reduced due to restructuring in the co-operation with PAL 18% of Group operating profit on New led by Discovery Bank. Streamlined some New initiatives to ensure focus on the businesses that generate significant economic value Bank continues to expand its current client base, and reached 1m accounts in the period -- 7 of 66 -- 8 Estimated CFR like seasonal flu during 4th and 5th waves COVID-19 less lethal however increased morbidity risk No evidence of increased mortality post-infection However, 1.4x higher risk of hospital admission post-infection 0.00% 0.02% 0.04% 0.06% 0.08% 0.10% 0.12% 0.14% 0.16% -11 -9 -7 -5 -3 -1 1 3 5 7 9 11 Months prior infection Months since recovery No evidence of increased mortality post infection 96x higher mortality risk In the period of infection 1. Source: Discovery Health Insights Initial analysis. To be submitted for peer review and publication 2. Assessed using COVID19 recovered clients randomly matched to individuals with no infection on recovery date, using the following features: age, sex, co-morbidity count, vaccination status, region, disease burden index, benefit option, prior flu vaccinations, oncology and chronic renal failure status. Population and matched controls are censored if either twin experiences scheme withdrawal or COVID19 infection. Recovery date based on the latter of 10 days post PCR collection date or COVID19 admission discharge date. 0.0% 0.5% 1.0% 1.5% 2.0% 2.5% 3.0% 3.5% 4.0% 4.5% 5.0% -11 -9 -7 -5 -3 -1 1 3 5 7 9 11 2.4x higher admission risk 1 month post recovery 1.4x higher admission risk 2-12 months post recovery 24x higher admission risk in the period of infection Months prior infection Months since recovery Mortality rate following confirmed infection 1.02% 2.07% 1.61% 0.13% D614G Beta Delta Omicron Season Flu CFR Range CFR 1 x Flu 7 x Flu 11 x Flu 14 x Flu R-factor 1.5 R-factor 2.3-4 R-factor 1.6 R-factor 1.6 -- 8 of 66 -- 9 Significantly de-risked the claims and lapse basis to allow for endemic COVID-19 and other risks Life companies were resilient throughout the pandemic Gross COVID-19 claims paid R7.2bn Discovery Life and VitalityLife - 1,000 2,000 3,000 4,000 5,000 6,000 7,000 8,000 FY20 FY21 FY22 Total Both DL and VL in strong position VLL SCRC 182% 183% 174% FY20 FY21 FY22 DL SCRC 197% 243% 214% FY20 FY21 FY22 330 144 Claims Lapses Short-term basis Long-term basis 550 294 Discovery Life estimated 1-year impact for FY23 of basis strengthening Rm Claims: • Strengthening of long-term mortality, capital disability and severe illness basis • Short-term stress assumptions to allow for heightened direct and indirect COVID-19 risks In addition: Refinements to shared-value model and other interventions significantly de-risks the basis Lapses: • Short and long-term adjustments to basis • Explicit policy alteration allowance -- 9 of 66 -- 10 Focus on scaling the key initiatives and streamlining the marginal ones Discovery Bank Discovery Business Insurance Umbrella Funds VitalityInvest Discovery Connect Expect continued growth Cogence AIA Health accounts >1m Expect rapid growth, 9 captive markets with 50m clients total staff 194 Modularising V1 services to make it more accessible and sellable V1 markets 24 Will be folded into businesses Despite strong growth, exiting VI due to market conditions Reviewing AIAH (Australia) to focus on Amplify Health strategy across Asia 1 Region Large scale initiatives Embedded in businesses Strategically reviewing Size Prospects DBI API R350m UF FUM R8.9bn new clients a day* c1-in-2 VitalityInvest AUA R15bn AIAH lives >50k *Connect new individual clients a day active clients 74% deposit vs loan book 2x deployment underway 1st lives 2.3m -- 10 of 66 -- 11 0% 5% 10% 15% 20% 25% 30% 2018 2019 2020 2021 2022 Bank Other SA UK VG Majority in Bank, expect spend to revert to long-term guidance 47% 13% 17% 23% Bank Other SA VG UK c60% of New is in Bank and Vitality Group New by strand Investment in New has been above guidance % core operating profit -- 11 of 66 -- 12 100 82 67 53 Bronze Silver Gold Platinum 100 78 66 53 41 Blue Bronze Silver Gold Diamond 100 53 46 33 Blue Bronze Silver Gold Discovery Health retention by status Vitality Shared-value model resilient during complex times Excellent persistency Resilience to COVID-19 Unexpected correlations Clear causality Discovery Life COVID-19 CFR by status Discovery Insure weather claims frequency by status Discovery Bank default rates by status Stability and positive selection Discovery Life claims and lapses At least partially vaccinated by status (%) Vitality Health lapses by status VG partner market claims and lapses Discovery Bank deposit by status 100 68 52 75 43 Blue Bronze Silver Gold Diamond Discovery Insure claims and lapses 100 85 75 60 Blue Bronze Silver Gold and Diamond 100 85 58 26 Blue Bronze Silver Gold and diamond 100 27 18 13 Blue Bronze Silver Gold 100 44 29 22 20 Blue Bronze Silver Gold Diamond 100 73 73 57 45 Blue Bronze Silver Gold Diamond 100 86 70 65 Blue Bronze Silver Gold and Diamond 100 28 6 4 Blue Bronze Silver Gold and Diamound 1 2 11 64 Blue Bronze Silver Gold and Diamond Vitality Life COVID claims as % total 100 25 5 13 Bronze Silver Gold Platinum 64 76 80 82 86 Blue Bronze Silver Gold Diamond -- 12 of 66 -- 13 Creating repeatability in the Vitality shared-value health insurance model Discovery Health Health Vitality Health International USA -- 13 of 66 -- 14 𝐶𝑙𝑎𝑖𝑚𝑠 𝑠𝑎𝑣𝑒𝑑 𝑀𝑎𝑟𝑘𝑒𝑡 𝑠ℎ𝑎𝑟𝑒 𝑐𝑜𝑠𝑡 𝑜𝑓 𝑓𝑖𝑙𝑙𝑖𝑛𝑔 𝑝𝑜𝑡ℎ𝑜𝑙𝑒> 112 448 Potholes filled since inception -- 14 of 66 -- 15 Opening EV Value of new business Unwind of risk discount rate Non-Economic Experience Variances and Methodology & Assumption Changes COVID-19 impact Operational EV Economic Experience Variances and Methodology & Assumption Changes Forex New Initiatives Other Closing EV 14.8% Group Embedded Value R86 258m R87 293m R74 645m Operational EV Economic and other ROEV -- 15 of 66 -- 16 15% 20% 25% 30% FY18 FY19 FY20 FY21 FY22 Group is well capitalised and highly liquid 1 Capital Adequacy Ratio 2 Comprehensive Cover Ratio, FY21 on C-ROSS I and FY22 on C-ROSS II 3 Considers SA Liquidity and liquid excess assets for Discovery Life, Discovery Insure, VitalityHealth, VitalityLife and Discovery Bank 4 SA cash + undrawn committed facilities SA Liquidity4, R millions FLR R millions Liquid excess assets above minimum regulatory capital requirements Strongly capitalised FLR within target Highly liquid across the Group3 Sufficient liquidity at the centre DHMS solvency (unaudited) 36% 23.8% 28% Jun 21 Cover Jun 22 Cover Life 1.8x 1.7x Insure 1.8x 1.2x VH 1.6x 1.5x VL 2.4x 2.1x Bank1 1.4x 1.3x PAH2 2.3x 2.8x - 500 1,000 1,500 2,000 2,500 3,000 FY18 FY19 FY20 FY21 FY22 - 2,000 4,000 6,000 8,000 10,000 12,000 14,000 16,000 FY18 FY19 FY20 FY21 FY22 -- 16 of 66 -- 17 Reported profit for the period affected by a few key factors Discovery Board continues to retain prior stated dividend position and decided not to declare an ordinary final dividend for the period ended 30 June 2022. The reintroduction of an ordinary dividend will be considered on an ongoing basis Rm 12 months ended 12 months ended % Jun-22 Jun-21 Normalised profit from operations 9 384 6 494 45% Economic assumptions adjustment - DL ( 651) ( 411) Economic assumptions adjustment – VL (net of all hedge impacts) 113 31 Finance charges excl. 1DP finance lease (1 376) (1 291) Unrealised gains/(losses) on foreign exchange contracts not designated as a hedge ( 2) ( 304) Foreign exchange gains/(losses) 155 ( 389) Expenses related to Prudential Book transfer ( 182) ( 187) Investment income and fair value remeasurements 210 83 Vaccination costs ( 157) ( 42) Gains from dilution of equity accounted investments 33 554 Other ( 258) ( 331) Profit before tax 7 269 4 207 73% Tax (1 790) ( 987) Profit attributable to preference shareholders ( 57) ( 63) Profit attributable to equity holders 5 422 3 157 72% Headline adjusting items ( 218) ( 171) Headline earnings 5 204 2 986 74% Economic assumptions adjustment (DL and VL) after tax and hedging 377 270 Other normalisation adjustments after tax 235 150 Normalised headline earnings 5 816 3 406 71% 1 2 3 1 2 3 SA saw an increase in nominal interest rates which partly recovered by 31 August 2022 UK saw increase in long term interest rates which benefits the business, partially offset by hedge effects and transfers to discretionary margin Weakening of the Rand compared to a strengthening in the prior period Continued investment in supporting the national vaccination campaign in SA -- 17 of 66 -- 18 Driving our purpose as a force for good in a complex ESG space Making people healthier 1 Restoring the climate and environment Strengthening healthcare system & nation building Ensuring diverse and inclusive workforce Ensuring fair and responsible pay 2 3 4 5 Focus areas and FY 2022 outcomes 470m >2m R11.4bn Healthy activities recorded1 Life years saved2 Shared-value dividend3 Lowest Carbon emitter4,5 17% Lower carbon emissions5 10% of medical sub-specialists trained6 of which 75% are in the public sector R200m Spend on mass vaccination campaign7 Female Black Staff 62% 84% Leadership 52% 64% Executive leadership 45% 36% 2nd of 14 Lowest income disparity ratio8 ESG Ratings Peer rating4 Highest 19.8 74% 71% 2022 2022 2021 1 Healthy activities include moderate and intense physical activity events recorded and HealthyFood purchases; 2 Life years saved is calculated from healthy activities recorded, using the methodology in the Rand research paper; https://d16pi0tqkfzkv3.cloudfront.net/assets/microsites/vitality-international/pdfs/rand-rr2870.pdf ; 3 Includes R5.2bn and R4.7bn Shared-value and rewards returned to customers respectively and R1.5bn DHMS dividend from Vitality; 4 Relative to domestic life insurance peer group; 5 Relative to 2019 base, measured by Scope 1 + Scope 2 emissions, before verification ; 6 Based on 10-year analysis, performed prior to 2022; 7 FY21 and FY22; 8 Relative to SA financial services group 4,8 -- 18 of 66 -- Growth in the three market-specific strategies -- 19 of 66 -- 20 1 2 3 The strategic strands Perfect composite model, #1 in our chosen segments in every industry, and the Bank pivoting to growth as the composite-maker within SA Best-in-breed products across businesses and operating as a fully integrated composite business with a seamless One Vitality client journey. A successful entry into motor insurance Leading wellness and healthcare platform that provides preeminent life and health insurers globally with our Vitality shared-value and health management capabilities to assist them in making their customers healthier, while ensuring their products are more competitive with better margins Discovery Insure Discovery Life Discovery Invest Discovery Bank Discovery Health Vitality Health Vitality Car Vitality Life USA -- 20 of 66 -- 21 Discovery Insure Discovery Life Discovery Invest Discovery Bank Discovery Health -- 21 of 66 -- 22 Jul-19 Nov-19 Mar-20 Jul-20 Nov-20 Mar-21 Jul-21 Nov-21 Mar-22 Total clients Total accounts Retail deposits Advances Operating result >510k >1.1m R11.2bn R4.5bn -R990m Discovery Bank 2018* 2019* 2020 2021 2022 Headline figures as at August 2022; operating result as at June 2022 *Includes capital development costs during build phase Jul-19 Nov-19 Mar-20 Jul-20 Nov-20 Mar-21 Jul-21 Nov-21 Mar-22 Jul-19 Nov-19 Mar-20 Jul-20 Nov-20 Mar-21 Jul-21 Nov-21 Mar-22 Jul-19 Nov-19 Mar-20 Jul-20 Nov-20 Mar-21 Jul-21 Nov-21 Mar-22 -- 22 of 66 -- 23 Key focus areas for the Bank Full-service offering 1 Differentiation and growth Shared- value 2 Quality and revenue 3 Digital capabilities Functionality and economics -- 23 of 66 -- 24 57% 26% 10% 4% New to Discovery 1 Product 2 Products 3 Products 4+ Products - 100 200 300 400 500 600 700 800 900 1,000 Jan-20 May-20 Sep-20 Jan-21 May-21 Sep-21 Jan-22 May-22 Growth of >800 clients per day with high engagement Close to 1 000 daily new business sales 57% new to Discovery iOS banking app download share >800 0% 50% 100% Jul-21 Jun-22 Self-assisted Direct Intermediated Intermediated sales grew Jul-21 Dec-21 Feb-22 Jun-22 FNB Standard Bank Absa Capitec Nedbank Discovery 74% clients are primary or active In line with DH’s 40% market share of open and closed schemes • Primary / highly active – ≥15% of net income as spend – for primary clients, salary deposits/ equivalent inflow • Active – <15% of net income as spend • Inactive – No activity or not in good standing Average daily new business sales per business day New business composition Engagement mix Channel mix 34% 40% 26% Primary / highly active Active Inactive New or low active -- 24 of 66 -- 25 Increasing credit penetration with superior credit quality New credit card market share by income pm New credit business by risk tier 69% 49% 15% 19% 7% 14% 9% 17% Market Discovery Exceptional low risk Low risk Medium risk High+ risk Bank A Bank B Bank C Bank D Bank E DSY 23% 14% 6% 2% Q1 FY21 Q2 FY21 Q3 FY21 Q4 FY21 Q1 FY22 Q2 FY22 Q3 FY22 3.5% 7.4% New credit market share Credit loss ratio vs market 5.10% 2.20% Big 4 average Discovery (incl overlays) As at Jun-22; FRB as at Dec-21 (Integrated Annual Reports) -- 25 of 66 -- 26 80% 90% 100% 110% 120% Q2 FY21 Q3 FY21 Q4 FY21 Q1 FY22 Q2 FY22 Q3 FY22 Q4 FY22 Cost of funds Retail net interest margin Revenue growth and digital scalability driving operating leverage Operating leverage Indexed to Jan-21 Breakeven earnings and sensitivities Strong revenue growth Bank 1 DSY Big 4 average Bank 2 Bank 3 Bank 4 Gross NIR pcpm vs market +19% Net interest margin 117% Indexed to Q2 FY21 92% Q1 FY21 excluded due to billing anomalies during the BIN migrations As at Jun-22; FRB as at Dec-21 (Integrated Annual Reports) 30% 40% 50% 60% 70% 80% 90% 100% 110% 120% Jan-21 Mar-21 May-21 Jul-21 Sep-21 Nov-21 Jan-22 Mar-22 May-22 Expenses pcpm Gross NIR pcpm Loss before tax pcpm* 67% 107% 40% R1.2bn FY22 FY23 FY24 FY25 FY26 FY27 Base Stretch Upside Daily sales : 1.2k by FY24 (stretch), 1.5k by FY25 (upside) Advances: +5% (upside) CLR: -5% (upside) NIR pcpm: +4% (stretch), +6% (upside) from FY24 *Once-off adjustments allocated evenly over the financial year Total revenue FY22 0 50 100 150 200 250 300 350 400 Q1 FY21 Q2 FY21 Q3 FY21 Q4 FY21 Q1 FY22 Q2 FY22 Q3 FY22 Q4 FY22 Total NII Gross NIR -- 26 of 66 -- 27 The case for the composite Discovery Life Discovery Health Discovery Insure Discovery Invest 30% market share 50% market share1 Top 3 New business growth3 3rd largest in net flows2 R1.5bn Financial impact of the Vitality wellness program on DHMS in 2021 R3.7bn Premium discounts and cash paybacks paid in FY22 R223m Premium discounts and fuel cash backs paid in FY22 R1bn Fee discounts, boosts and paybacks paid in FY22 Discovery Bank Same architecture Consumer use; digital ecosystem and engagement platform Security and integrated payment systems Discovery Miles store of value Shared- value created Market share Same architecture HEALTH HEALTH DRIVE 1 DH market share excluding GEMS, 39% including GEMS 2 Excluding white labelled funds 3 based on best estimate of competitor new business numbers Discovery Life Discovery Health Discovery Insure -- 27 of 66 -- 28 SA Composite Single-view, consistent architecture and unique digital capabilities -- 28 of 66 -- 29 Discovery Insure Discovery Life Discovery Invest Discovery Bank Discovery Health -- 29 of 66 -- 30 Discovery Health Membership Non-scheme growth Operating profit New business to R7 292m +20% lives under administration >3.7m to R3 600m +5% lives >263k revenue R1.2bn 1993 1995 1997 1999 2001 2003 2005 2007 2009 2011 2013 2015 2017 2019 2021 Non Scheme Products Restricted Schemes DHMS 2018 2019 2020 2021 2022 2018 2019 2020 2021 2022 Jan-18 Jun-18 Nov-18 Apr-19 Sep-19 Feb-20 Jul-20 Dec-20 May-21 Oct-21 Mar-22 Flexicare Gap Cover Healthy Compay Healthy Company -- 30 of 66 -- 31 DHMS Discovery Health Medical Scheme performance summary Membership Flight to stability persists Solvency market share: 57.6% credit rating AAA unaudited reserves at June 2022 R28.3bn 0% 2% 4% 6% 8% 10% 12% 2018 2019 2020 2021 2022 Stable lapses 5.2% Resilient membership base 1 DHMS Rest of Industry Others 94.6% 2.9% 2.5% 94.5% 2.6% 2.9% 94.6% 2.4% 3.0% 96.5% 1.9% 1.6% 96.8% 1.7% 1.6% 2018: 2019: 2020: 2021: 2022: 0% 5% 10% 15% 20% 25% 30% 35% 40% - 5 10 15 20 25 30 35 2018 2019 2020 2021 2022 R billion Reserve Actual Solvency Required Solvency R6.8bn returned to members through deferred contribution increases unaudited solvency at June 2022 36% Annualised lapse rate excludes turnover members: i.e. members from existing employer groups who leave their employment and are subsequently replaced. -- 31 of 66 -- 32 Growth deep-dive Growth from all types of business DHMS growth in stark contrast to market Higher levels of Vitality- integrated DHMS policies 2020 2021 2022 2.1x improved surplus per life Vitality members contribute significantly to the overall health of the scheme: 15% lower admission rates 38% lower lapses 2018 2019 2020 2021 2022 57% from employer groups: 43% from individuals: 2018 2019 2020 2021 2022 Heathier new joiner profile: DHMS Open Schemes Average age 26.1 27.6 Chronic ratio 6.5% 9.3% Gross, net and withdrawing lives over last 18 months 1 Gross lives Left employer Affordability Provider change Death Emigration Other +241k gross +46k net Withdrawing & net lives -- 32 of 66 -- 33 Discovery Connect | End-to-end D2C capability powered by industry-leading technology and analytics Strong in-force policy growth reflecting the quality of new business Health connect sales as % of individual policies sales from FY16-FY22 Jul-17 Nov-17 Mar-18 Jul-18 Nov-18 Mar-19 Jul-19 Nov-19 Mar-20 Jul-20 Nov-20 Mar-21 Jul-21 Nov-21 Mar-22 Jul-22 2.6x 336 877 In-force book (policy-lives ‘000, all products activated via Connect) 0% 10% 20% 30% 40% 50% 60% 70% FY16 FY17 FY18 FY19 FY20 FY21 FY22 -- 33 of 66 -- 34 DHMS: An industry-first activation journey ADVANCED AI- DRIVEN PLAN SELECTION OPTIMISED CUSTOMER JOURNEY AUTOMATED, EFFICIENT UNDERWRITING SECURE PROCESS IMMEDIATE ACTIVATION -- 34 of 66 -- 35 Discovery Insure Discovery Life Discovery Invest Discovery Bank Discovery Health -- 35 of 66 -- 36 SCR coverage 174% 2022 3,112 2022 1xILT Liquidity coverage 125% SCR target 29.0% 30.2% Discovery Life Normalised operating profit to R4 028m +200% Strong capital and liquidity 2018 2019 2020 2021 2022 New business API to R2 543m +12% Maintained leading market share position NMG Market Share survey Q1+Q2 2022 2016 2017 2018 2019 2020 2021 2022 First 6 months of 2021 First 6 months of 2022 -- 36 of 66 -- 37 Discovery Life remained resilient through COVID-19 Jun 2020 Aug 2020 Oct 2020 Dec 2020 Feb 2021 Apr 2021 Jun 2021 Aug 2021 Oct 2021 Dec 2021 Feb 2022 Apr 2022 Jun 2022 Wave 1 = R538m Wave 2 = R1 871m Wave 4 = R373m Wave 3 = R3 940m Wave 5 = R108m Provisions sufficient Gross claims paid decreased substantially during H2 FY22 FY21 FY22 IFRS claims provision utilisation* 96% *Excludes IBNR of 4% Individual Life total COVID-19 provision available vs utilisation 22 1,673 1,769 0 1,976 2,398 FY20 FY21 FY22 Net COVID-19 Claims Provision available in period Claims Lapses Lapses Claims Gross claims paid in FY22 R3.7bn Cashflow impacted by COVID-19 claims Rm Premium and fees Claims Operational costs Cashflows from existing New business strain and net finre Net cashflow excl COVID-19 COVID-19 Impact Net cashflow after COVID-19 869 3 629 17 478 -245 R869m Net cashflow before COVID-19 -- 37 of 66 -- 38 658 Lapses and surrenders Mortality and morbidity Premium and fee income Policy alterations Other Total Embedded value growth driven by positive operating variances to R38.4bn Life and Invest embedded value Rbn +10.5% VNB and margin impacted by higher interest rates and lower volumes Positive non-economic experience variances Life & Invest FY 2022 (Rm) 411 365 2021 2022 5.7% 5.3% 2021 2022 VNB (Rm) Life: VNB margin (%) Life: Persistency offset higher than expected morbidity experience June 2021 New business Expected unwind incl New Business Experience Variances Methodology and Assumption Changes Total before Economic Impact Experience Variances Methodology and Assumption Changes Components below the line June 2022 34.8bn 38.5bn 38.4bn Economic Non- economic -- 38 of 66 -- 39 Discovery Insure Discovery Life Discovery Invest Discovery Bank Discovery Health -- 39 of 66 -- 40 Discovery Invest +7%to R2 920m 2018 2019 2020 2021 2022 +11%to R1 204m +4% 10% lower income drawdowns 43% lower investment lapses in shared-value benefits accrued and paid to clients R13.3bn Since the launch of shared value: 2018 2019 2020 2021 2022 2018 2019 2020 2021 2022 to R122bn H1 H2 Shareholder Weighted All Share 6.6% -7.2% S&P 500 Index (USD) 10.9% -20.6% NASDAQ Composite (USD) 7.9% -29.5% Assets under Administration 9.5% -4.6% Market volatility in H2 affected AuA growth Normalised operating profit Assets under administration Shared-value outcomes New business -- 40 of 66 -- 41 World’s first shared-value DFM with BlackRock and RisCura providing independent fund selection with boosts on the entire solution Combination of factors led to opportunity for shared-value behavioural investment platform ACCESS THE WORLD’S BEST INVESTMENT CAPABILITIES THROUGH BLACKROCK 113 Markets across the globe $472 bn BlackRock sustainable AUM* UNDERPINNED BY ALADDIN WEALTH™ TECHNOLOGY 2 100+ 3 000+ Dedicated developers and product managers Risk factors monitored daily USE VITALITY TO PROVIDE PATHWAYS TO BETTER RETIREMENT *Source: BlackRock as at June 2022 Transfer of risk to investors through Defined Contribution funding plans Technology platforms democratising asset management capabilities Increase in complexity of investment markets Behavioural and demographic risks are important but have largely been ignored -- 41 of 66 -- 42 Discovery Insure Discovery Life Discovery Invest Discovery Bank Discovery Health -- 42 of 66 -- 43 2018 2019 2020 2021 2022 Discovery Insure Gross new business Gross written premium to R4 762m1 to R1 246m2 2018 2019 2020 2021 2022 1 Personal lines figures only 2 Figures excluding VAT 3 Normalised operating profit includes Personal lines and Cambridge Mobile Telematics -3% +13% Market share in GWP Assuming 6% annual market growth 7% Vehicles insured +5%to 296 0001 Normalised operating profit to –R162m3 -165% 2018 2019 2020 2021 2022 CMT Personal lines 2018 2019 2020 2021 2022 2018 2019 2020 2021 2022 -- 43 of 66 -- 44 Adverse weather and supply-side inflation had the largest claims impact 1 Shipping cost index: https://fbx.freightos.com 2 El-Nino Southern Oscillation Index. Jul 2022 to Dec 2022 numbers are predictions: https://origin.cpc.ncep.noaa.gov/products/analysis_monitoring/ensostuff/ONI_v5.php/ Contribution to total claims overrun $- $2 $4 $6 $8 $10 $12 Thousands Rapid rise in shipping costs1 100 85 75 60 Blue Bronze Silver Gold and Diamond Relative motor claim severity by status 4x 0% 5% 10% 15% 20% A B C D E F G H I J Vehicle make 2021 2022 Adverse weather | Longer rainy season and KZN floods Longer rainy season increased claim costs2 KZN storm: the largest CAT event in Insure history 100 86 70 65 Blue Bronze Silver Gold and Diamond Relative weather claim frequency by status Jan-10 Jan-11 Jan-12 Jan-13 Jan-14 Jan-15 Jan-16 Jan-17 Jan-18 Jan-19 Jan-20 Jan-21 Jan-22 - 50 100 150 200 Feb 15 Nov 15 Jan 16 Feb 16 Jul 16 Nov 16 Jun 17 Oct 17 Dec 17 Apr 19 Dec 19 Apr 22 Rm FY22-23 High motor parts inflation for top 10 vehicle makes Supply-side inflation | Motor inflation exceeded expectations R369m claims overrun due to adverse claims experience 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% Adverse Weather Supply side Inflation Power surge Other Total claims overrun 44% Adverse weather 28% Supply-side inflation -- 44 of 66 -- 45 Corrective actions implemented to manage impact Selective lapsation experienced 90% 95% 100% 105% 110% Actual Premium Projected premium with H1 growth Higher average premium growth 60% 70% 80% 90% 100% 110% 120% Premium growth AvE lapse experience 98 258 Retained clients Excess lapses 2.5x Quality client base retained Relative historical loss ratios 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% Additional margin generated Repeatable claims Net position Actions generated additional margins Claims relative to margin Lapses by status 74% Blue Bronze Silver Gold and diamond Gold and Diamond -- 45 of 66 -- 46 Vitality Health Vitality Car Vitality Life -- 46 of 66 -- 47 Lives covered UK Composite Normalised operating profit New business GBP millions GBP millions GBP millions Best-in-breed products across businesses and operating as a fully integrated composite business with a seamless One Vitality client journey to £893m to £98.7m +28% +8% +12% +22% to £148.1m to 1.56m lives 2018 2019 2020 2021 2022 2018 2019 2020 2021 2022 Vitality Health, Vitality Life, Vitality Car 1 Vitality Health and Vitality Life only Earned premiums1 2018 2019 2020 2021 2022 2018 2019 2020 2021 2022 Vitality Health Vitality Car Vitality Life -- 47 of 66 -- 48 Consolidated UK Embedded Value Opening as at 30 Jun '21 VL Part VII Delay Experience variances Assumption changes Methodology and modelling changes Shareholder capital injected Other Closing as at 30 Jun '22 £72.5m £35.5m £45.4m £12.6m £9.0m £37m £1 002m £790m 2019 2020 2021 2022 Consolidated UK EV Exceeding the £1 billion mark £1 002m £790m £735m £840m Robust performance through the pandemic -- 48 of 66 -- 49 Vitality Health Normalised operating profit Earned premiums Lives covered New business GBP millions GBP millions GBP millions to £560.2m to £65.6m +43% +9% +15% +30% to £85.8m to 839k lives 2018 2019 2020 2021 2022 2018 2019 2020 2021 2022 2018 2019 2020 2021 2022 2018 2019 2020 2021 2022 -- 49 of 66 -- 50 Lives 2019 New business growth Retention Lives 2022 Lives 2019 New business growth Retention Lives 2022 Deploying data-driven approaches in an excellent operational environment to amplify benefits across the value chain Attract Price Engage Retain Advanced analytics and ML models support direct sales activity and advertising investment Price optimisation and personalised pricing drive profitable new business and renewals ML models drive personalised wellness recommendations; sophisticated digital tools aid health system navigation ML models and advanced analytics drive proactive retention Profit uplift= 2019 2022 £560m £460m 16% Of membership growth attributable to new business growth 22% Increase in earned premium 84% Of membership growth attributable to retention performance 16% 642k 839k 84% 22% 30% Operating margin uplift Earned premium uplift Increase in normalised operating profit 58% = Musculoskeletal Oncology Cardiac -31% -37% -46% Engagement driving down healthcare costs Active Rewards points 839k 642k -- 50 of 66 -- 51 Strategically positioned to further enhance a strong presence in the UK healthcare environment NHS waiting list has been growing Demand for VH’s Primary Care services has grown substantially Total number of people waiting to begin treatment Percentage of claims that are Primary Care 0% 10% 20% 30% 40% 50% 2015 2016 2017 2018 2019 2020 2021 2022 Vitality GP Talking Therapies Physiotherapy Over 45% in 2022 Source: NHS England Statistical work areas 0 1,000,000 2,000,000 3,000,000 4,000,000 5,000,000 6,000,000 7,000,000 8,000,000 6.7 million People waiting to receive treatment -- 51 of 66 -- 52 Vitality Life Normalised operating profit Earned premiums Lives covered New business to £333m +7% +9% to 722k lives GBP millions GBP millions GBP millions to £33.1m +7% +13% to £62.3m 2018 2019 2020 2021 2022 2018 2019 2020 2021 2022 2018 2019 2020 2021 20222018 2019 2020 2021 2022 -- 52 of 66 -- 53 0.0% 0.5% 1.0% 1.5% 2.0% 2.5% 3.0% Jul-21 Oct-21 Jan-22 Apr-22 Jul-22 Significantly strengthened the back book Bronze Silver Gold Platinum Successful deferral of Part VII Hedging strategy recouped past interest rate losses Exceptionally strong retention performance Strong shared-value dynamics through the pandemic Jul-19 Feb-20 Sep-20 Apr-21 Nov-21 Jun-22 Expected -25% Lapses AvE -13% -19% -51% 25 Year Swap Rate for FY22 Swaption began generating value at 1.15% Liquidity timing risk Effective hedging directly on Prudential Balance Sheet Capital Risk to do Part VII Operational complexity Sustainable commercial terms After Before 1 2 3 4 5 Part VII transfer now indefinitely deferred, de-risking the business going forward Bronze Silver Gold Platinum AvE mortality rates for optimised policies AvE lapse rates for optimised policies -25% -16% -47% -- 53 of 66 -- 54 USA -- 54 of 66 -- 55 Vitality Global divided into two pillars, both designed to optimally capture the global potential of Discovery IP Vitality Network Vitality Health International Product/ Service Commercial Model to a global network of world-class insurers in a highly cash-focused commercial model The A fully integrated behavioural-change programme underpinned by a supporting tech platform, data & consulting services Description through successful equity positions in a select number of high potential HealthTech and health insurance ventures HealthTech behaviour-change solutions for public and private payers, and providers Health insurance in fast-growing emerging markets Shared-value health insurance approach Global Vitality Network Vitality Health International -- 55 of 66 -- 56 Vitality Global excluding Ping An Health Vitality Global revenue Vitality Global operating profit 2018 2019 2020 2021 2022 to $31.4m to $100.4m Integrated API by Insurance Partners to $1.4bn 2018 2019 2020 2021 2022 Insurance partners membership to 3m 2018 2019 2020 2021 2022 Vitality Network 2018 2019 2020 2021 2022 Insurance Markets +29% Vitality USA -- 56 of 66 -- 57 Vitality Network | Drivers of growth 41% 44% 56% 59% 64% 30% 35% 40% 45% 50% 55% 60% 65% 70% 200 400 600 800 1000 1200 1400 1600 Partner API & penetration rates API Penetration rates 2021 2022 Present value of existing contract revenues This represents the sum of the future expected revenue from Vitality Group’s insurance partnerships based on latest internal forecasts at a discount rate of risk-free + 10% at each point in time for variable revenue and risk-free for guaranteed revenue New contracts & sources of income Growth in existing markets above expectations Methodology & assumption changes Economic experience variances Expected PV of revenue from existing contracts $989m $1.1bn FY18 FY19 FY20 FY21 FY22 Membership (millions) 0.8 1.4 1.8 2.4 3.0 FY18 FY19 FY20 FY21 FY22 Integrated products 101 128 160 182 191 FY18 FY19 FY20 FY21 FY22 FY18 FY19 FY20 FY21 FY22 14 18 21 27 30 Number of Vitality Network markets +9% >$1bn Growth enabled and fuelled by new products & new channels -- 57 of 66 -- 58 VHI | High potential HealthTech & insurance ventures in key geographies USA HEALTH AFRICA Health insurance HealthTech The largest and most profitable health insurer in China, with growth that exceeds competitors lives Digital health technology and solutions business, with an addressable market of US$100 billion US corporate wellness business expanding into HealthTech Pan African wholly owned subsidiary operating with local partners in different African countries Joint venture providing advanced data science & predictive analytics services to health industry clients in multiple regions technology & health-IP assets developed over >30 years with >200 employees building the business lives with an engagement rate that increased by 30% off an already high base rate markets launched within first 6 months increase in profits in FY22, with an increase in revenue of 22% -- 58 of 66 -- 59 Integrated capabilities across the entire health insurance and healthcare value chain >500m unique claims 1bn physical activity data points >10TB behavioural data >10m hospital admissions Extensive data sets 75% 25% Transforming AIA through world-class technology AIA providing initial capital and has a captive base of ~50m clients (>14m health and >160k corporates) across 9 key geographies Discovery is a global innovator in health insurance with 30 years of experience and execution track record Capital-light and technology-centric insurtech business >$100bn addressable market opportunity in Asia for digital health and technology services by 2030 Symptom checker & triage Patient coaching platform Integrated patient management Electronic health records Mental wellness Virtual consultations Electronic scripts & delivery Medicine adherence Nutrition & weight management AIA Vitality Digital Health Platform and Solutions Integrated digital health solutions driving engagement, greater convenience and efficiencies Disease management High-risk patient management Disease prevention Care co-ordination Provider integration Advanced illness management Payment options Family history & risks Case mngt automation Pricing optimisation Medical Cost Optimisation Digital tools and analytics supporting high-quality, cost- effective care Insurance pricing Underwriting algorithms Contract & tariff mngt Pharma benefit mngt Digital pre- authorisation Product design enhancement Health claims processing Clinical data integration Complex benefit STP Formulary mngt Benefits and Policy Management Highly flexible, automated and agile end-to-end policy admin, claims and benefit systems Population health insights Disease burden indices Clinical technology Fraud, waste & abuse Policy renewal optimisation Frequency & utilisation Clinical auditing Claims and behaviour Operational improvement Clinical predictions Data, Analytics and Health Intelligence Advanced data management and analytics for personalisation and value generation -- 59 of 66 -- 60 progress update Officially launched 1 March 2022 Full executive team and senior management layer appointed, and best-in-class technology and data science teams appointed 194 total staff complement Substantial progress in transfer of 5 major technology platforms from DSY to AIA – completed by end 2022 7 technology solutions being developed for implementation in AIA markets and for external public and private clients in APAC region First solution deployment underway in one of AIA’s large health insurance businesses Extensive market development work with all AIA health insurance businesses almost completed – expected to lead to substantial programme of solution deployment over next 5 years Active engagement with potential government and private sector clients in Singapore Significant progress towards acquisition of a leading AI and data analytics business in Singapore – expected to be complete before end 2022 -- 60 of 66 -- 61 Written premium1Lives Ping An Health 1 100% of PAH PAH’s operating results pre-tax to R2.5bn (DSY’s share is R622m) Discovery’s operating result after tax to R338m 2018 2019 2020 2021 2022 to R45.2bn PAH insurance licence PAH insurance licence Reinsurance PAH insurance licence Reinsurance RMB 6.57bn 2019 2020 2021 2022 Net assets 2018 2019 2020 2021 2022 Profit before investment income and gains Investment income and gains profit growth before investment income 2018 2019 2020 2021 2022 8.9 13.5 17.6 19.4 1.7 7.8 13.0 7.9 Jun-19 Jun-20 Jun-21 Jun-22 -- 61 of 66 -- 62 2001 2004 2007 2010 2013 2016 2019 Out-of-pocket Voluntary Insurance Compulsory Contributions (SHI) 14.3% CAGR $189 $46 $300 China’s private health insurance prospects remain positive, despite COVID-related headwinds Short-term economic strain due to COVID-related restrictions on movement and activity Medium-term economic outlook remains positive Private health insurance industry set to build on strong fundamentals High risk population remains under- vaccinated 52m people > 60 years unvaccinated1 Healthy China 2030 Rising middle-class with higher income Middle class expected to double in next decade Higher income for aging population over the next five years +100% +26% Severe GDP impact3 Policies emphasise developing private healthcare and private health insurance, amongst others Estimated GDP growth3 COVID-related excess deaths potentially reaching 1.5 million2 5.5% 3.3% 2022 Target 2022 Forecast 0.4% growth in Q2 2022 2022 EIU Forecast 5.0% 4.7% 4.4% 4.2% 2023 2024 2025 2026 Healthcare expenditure growing, including private expenditure (Current USD per capita)4 Source: 1. Economist April 2022 Edition; 2. Reuters 2022-05-10 ; 3. Economist Intelligence Unit, September 2022; 4. World Health Organisation, Global Health Expenditure Database -- 62 of 66 -- 63 2021 2022 Group channel Non-PAL cross-selling Other PAL individual channel Diversified distribution channels and continued expansion ensure resilient and persistent growth in sales on PAH’s insurance licence Shift towards non-PAL channels +51% +31% 35% 42% -9% -23% Distribution channels continue to expand both offline and online Beijin g Heb ei Tianji n Jiangs u Shanghai (HQs) Zheijian g Sichua n Guangdong Shenzhe n Hen an Hubei Liaoni ng Chongqi ng Shandong Fujia n Huna n PAH licensed regions PAH unlicensed regions PAH licensed regions represent 58% of GDP2 Offline branch network 16 Branches Multi-channel online distribution Ping An Health online Ping An APPs SuiShenYi Online management of high-quality advisor network Expand PAH operated WeChat & APP channels Partner with online platforms in Ping An Group 1 100% PAH | 2 Source: China statistical yearbook 2021 edition 2018 2019 2020 2021 2022 New business1 -15% to R11.5bn PAH insurance licence +6% PAH insurance licence Reinsurance -- 63 of 66 -- 64 Ping An Health’s growth rate exceeds the market and profitability is outperforming key competitors CBIRC regional monthly premium data, commercial health insurance for medical reimbursement (excluding CI premium); published annual financial statements PAH remains resilient during recent difficult market conditions 63% group insurance growth rate, ahead of competitors Highest profit margins among leading specialist health insurers 1.01 0.37 0.36 1.64 0.46 0.28 Ping An Health Cigna MSH Premium income RMB billions Premium income Jan-Jun 2022 Premium income Jan-Jun 2021 +63% +26% -22% Company 2020 2021 Ping An Health Insurance Company 5.4% 6.7% Kunlun Health Insurance Co Ltd -19.5% 2.7% CPIC Health 2.1% 2.3% PICC Health Insurance Company Limited 0.8% 0.1% Fosun United Health Insurance Company Ltd 0.6% -3.4% Ruihua Health Assurance Corporation -7.9% -26.5% Annual profitability analysis of top 6 specialist health insurers in China at December 2021 Margin calculated as net profit/operating revenue Total premium growth rate (%) January to June 2022 -0.7% 22.6% Health insurance market average premium growth PAH premium growth -- 64 of 66 -- 65 Positioned for growth off a strong foundation The leading new generation financial services organisation which through its Vitality Shared-value model makes customers healthier, provides better and more sustainable products, achieves superior growth and returns for its shareholders and is a force for good in the communities in which it operates Normalised operating profit +45% to R9 384m Normalised headline earnings +71% to R5 816m Headline earnings +74% to R5 204m +5% new business API, including DH take- on of new closed schemes and gross revenue for Vitality Group Core new business +6% to R21 710m -- 65 of 66 -- AUDITED RESULTS for the year ended 30 June 2022 -- 66 of 66 --